跳至主要内容
临床试验/CTRI/2018/03/012301
CTRI/2018/03/012301尚未招募4 期

Pre and post treatment expression of CD 163 in OSMF and role of CD 68, CD 163 and STAT1 as potential biomarkers in OPMD

Maulana Azad Institute if Dental Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Clinically and Histopathologically proven cases of OSMF 1)Positive history of chewing arecanut or one of its commercial preparation 2)Restricted mouth opening and changes in oral mucous membrane including presence of vertical fibrous bands stiffness and blanching 3)Positive history of tobacco smoking, betel quid and alcohol

排除标准

  • Those who are not willing to participate Patients with severe systemic disease Patient who are already undertaking some treatment for potentially malignant disorder

研究者

发起方
Maulana Azad Institute if Dental Sciences

相似试验